Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumors × pazopanib × Clear all

Phase

Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Sarcoma 5 Ovarian Neoplasms 4 Neurofibrosarcoma 2 Hemangiosarcoma 2 Vascular Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors 1 Solid Tumor, Adult 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Relapsed Pediatric Solid Tumor 1 Osteosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Histiocytoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1 Granular Cell Tumor 1 Glomus Tumor 1 Glioblastoma 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 4 Nivolumab 2 Injections 2 Docetaxel 2 taxane 1 pazopanib 1 palbociclib 1 lenvatinib 1 demplatin pegraglumer 1 cobimetinib 1 birinapant 1 Topotecan 1 Tablets 1 ODM-207 1 Infusions, Intravenous 1 HLA-A*24:02 antigen 1 Gemcitabine 1 E-3810 1 CB-839 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02303028 2022-06-28

TOPAZ

The Hospital for Sick Children

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡